Si-Hwan Song
Fortune : 435 965 $ au 30/06/2026
Fortune : 435 965 $ au 30/06/2026
Si-Hwan Song currently works at CORESTEMCHEMON, Inc., as Co-President & Director from 2000.
Dr. Song also formerly worked at CHEMON, Inc., as Chief Executive Officer & Director and Ebest Special Purpose Acquisition 2 Co., as Director.
Dr. Song received his doctorate degree from Seoul National University.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
CORESTEMCHEMON INC. 0,59 % | 29/03/2026 | 311 981 ( 0,59 % ) | 435 965 $ | 30/06/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| CORESTEMCHEMON INC. | President | 01/08/2000 |
| Sociétés | Poste | Fin |
|---|---|---|
| CHEMON INC. | Directeur Général | - |
Ebest Special Purpose Acquisition 2 Co.
Ebest Special Purpose Acquisition 2 Co. Investment ManagersFinance Special Purpose Vehicle | Directeur/Membre du Conseil | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 4 |
|---|---|
Seoul National University
Seoul National University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CORESTEMCHEMON, Inc.
CORESTEMCHEMON, Inc. Pharmaceuticals: MajorHealth Technology Develops and distributes cell & gene therapy products | Health Technology |
Ebest Special Purpose Acquisition 2 Co.
Ebest Special Purpose Acquisition 2 Co. Investment ManagersFinance Special Purpose Vehicle | Finance |
CHEMON, Inc.
CHEMON, Inc. Medical/Nursing ServicesHealth Services Engages in research and development of medical sciences | Health Services |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national